The implications are substantial: A shift from symptom management to endogenous tissue restoration A credible pathway for post-injury prevention of degenerative joint disease A realistic translational bridge, given prior Phase 1 human safety data Equally important is the broader signal this sends: preservation of functionespecially in kneesis foundational to mobility, workforce readiness, injury recovery, and long-term independence
Week 1-2 Protocol: Begin with 100mcg administered once daily Optimal timing: morning administration on an empty stomach Monitor and document any observable changes Maintain consistent injection sites (rotating between abdomen, thighs) Week 3-4 Adjustment: If well-tolerated, increase to 150mcg daily Continue once-daily administration schedule Assess response patterns and document findings Consider splitting dose if preferred (75mcg twice daily) The subcutaneous route of administration remains the gold standard for KLOW blend peptide delivery
Vitamin C 40 mg Supports collagen production and enhances glutathione effect
Injecting air creates positive pressure inside the vial that forces liquid back through the needle tract on subsequent draws, introducing contaminants that compromise sterility over the 28-day use window
Can I take Citrucel if I am already experiencing a GLP-1 blockage
